The health-care corner of the US equity market has traditionally been viewed as defensive, thanks to steady growth and healthy dividend yields among the industry’s stalwarts. That narrative is changing.
Following years of underperformance relative to the broader market, health care staged a turnaround last quarter, posting the best performance among the 11 major industry groups in the S&P 500 Index.